Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial
Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page
- Check2 days agoChange DetectedThe history page now shows a new site revision label, v3.6.2, replacing the previous v3.6.0. This reflects a system update to the page history rather than changes to the study record.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe history now shows recruitment closed with 'No longer looking for participants'. The revision history was updated to add 'Revision: v3.6.0' and remove 'Revision: v3.5.5'.SummaryDifference0.4%

- Check23 days agoChange DetectedA new release entry appears in the study's history for version v3.5.5, replacing the previous v3.5.4 in the history. This reflects an update to the page's release notes rather than changes to the study data.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry, v3.5.4, has been added to the history, and the previous v3.5.3 entry has been removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s footer indicates an updated ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3. This reflects a platform/version change rather than a change to the study record details.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.